Eosinophil infiltration in three patients with generalized atrophic benign epidermolysis bullosa from a Japanese family: molecular genetic and immunohistochemical studies
- PMID: 16172808
- DOI: 10.1007/s10038-005-0282-4
Eosinophil infiltration in three patients with generalized atrophic benign epidermolysis bullosa from a Japanese family: molecular genetic and immunohistochemical studies
Abstract
Generalized atrophic benign epidermolysis bullosa (GABEB), a subtype of epidermolysis bullosa (EB), is an autosomal recessive skin disease characterized by derm-epidermal separation leading to skin fragility and atrophy and other associated abnormalities. Although a few reports demonstrated that eosinophils are infiltrating beneath bullas in infants with some types of EB, no such condition in adult GABEB patients has been known. Here we report on three adult patients with GABEB from a Japanese family, whose bullous skin lesions showed massive eosinophil infiltration. One of the three patients showed amyloid deposition at the intestine, kidney, and skin. Linkage analysis revealed that GABEB in the family was linked to COL17A1 with a maximum LOD score of 3.08. Mutation analysis identified in the three patients a homozygous insertional mutation, 209-210insCA, in exon 5 of COL17A1. The expression of mutated COL17A1 was confirmed by semiquantitative RT-PCR, but no signals for truncated COL17A1 protein were detected by the immunohistochemical studies using antibodies against BP180. Furthermore, no autoantibody against the mutant protein was detected by western blot analysis. It is thus less likely that autoantibody and/or a local immune reaction in their skin has a primary role in eosinophil infiltration in these patients.
Similar articles
-
LAMB3 mutations in generalized atrophic benign epidermolysis bullosa: consequences at the mRNA and protein levels.Lab Invest. 1998 Jul;78(7):859-67. Lab Invest. 1998. PMID: 9690563
-
Generalized atrophic benign epidermolysis bullosa. Either 180-kd bullous pemphigoid antigen or laminin-5 deficiency.Arch Dermatol. 1996 Feb;132(2):145-50. doi: 10.1001/archderm.132.2.145. Arch Dermatol. 1996. PMID: 8629821
-
180-kD bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa.J Clin Invest. 1995 Mar;95(3):1345-52. doi: 10.1172/JCI117785. J Clin Invest. 1995. PMID: 7883981 Free PMC article.
-
Generalized atrophic benign epidermolysis bullosa.Adv Dermatol. 1997;13:87-119; discussion 120. Adv Dermatol. 1997. PMID: 9551142 Review.
-
Immunohistochemical, ultrastructural, and molecular features of Kindler syndrome distinguish it from dystrophic epidermolysis bullosa.Arch Dermatol. 1997 Sep;133(9):1111-7. Arch Dermatol. 1997. PMID: 9301588 Review.
Cited by
-
IgG autoantibodies in bullous pemphigoid induce a pathogenic MyD88-dependent pro-inflammatory response in keratinocytes.Nat Commun. 2025 Aug 6;16(1):7254. doi: 10.1038/s41467-025-62495-2. Nat Commun. 2025. PMID: 40769980 Free PMC article.
-
A Review of Acquired Autoimmune Blistering Diseases in Inherited Epidermolysis Bullosa: Implications for the Future of Gene Therapy.Antibodies (Basel). 2021 May 17;10(2):19. doi: 10.3390/antib10020019. Antibodies (Basel). 2021. PMID: 34067512 Free PMC article. Review.